Product Information

DOXEPIN 50 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1535 per EA under NDC 62332064531. Its NADAC has been published 254 times since Oct 13, 2021.

FDA first approved this application on Apr 21, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN 50 MG CAPSULE

DOXEPIN HYDROCHLORIDE
$0.1535per EA

Strength

50 mg/1

NDC

62332064531

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215076

FDA Approved

4/21/2021

TE Code

AB

On Market Since

4/23/2021

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN 50 MG CAPSULE has been published 254 times since Oct 13, 2021, and over the history we have for it it has declined 66.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1535 per EA
All-time high$0.4578 (Oct 13, 2021)
All-time low$0.1165 (Nov 20, 2024)
52-week high$0.1606
52-week low$0.1441
Median price$0.2275
Average price$0.2382
Largest weekly change-37.5% (Nov 20, 2024)
Weeks tracked254
Tracking sinceOct 13, 2021

Price History

1W

+3.8%

1M

+3.8%

3M

+1.3%

6M

+0.1%

1Y

-4.5%

3Y

-43.2%

5Y

N/A

All

-66.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DOXEPIN 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.1535 per EA (NDC 62332064531), effective Aug 19, 2026.

How has the price of DOXEPIN 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 66.5%. It has been tracked across 254 weekly CMS publications since Oct 13, 2021.

What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?

Since Oct 13, 2021, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.4578 (Oct 13, 2021), with a median of $0.2275 per EA.

Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXEPIN 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXEPIN 50 MG CAPSULE?

DOXEPIN 50 MG CAPSULE (NDC 62332064531) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.